MetLife, Inc. (BVMF:METB34)
Brazil · Delayed Price · Currency is BRL 407.54
-11.84 (-2.82%)
At close: Jan 20, 2026
MetLife Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 54,782 | 49,919 | 49,435 | 53,735 | 46,396 |
Total Interest & Dividend Income | 22,559 | 20,127 | 19,404 | 14,994 | 21,326 |
Gain (Loss) on Sale of Investments | -1,145 | -1,152 | -2,727 | -1,065 | 1,596 |
Other Revenue | 888 | 2,088 | 789 | 1,100 | -630 |
| 77,084 | 70,982 | 66,901 | 68,764 | 68,688 | |
Revenue Growth (YoY) | 8.60% | 6.10% | -2.71% | 0.11% | 1.25% |
Policy Benefits | 59,071 | 53,456 | 53,027 | 54,221 | 49,397 |
Policy Acquisition & Underwriting Costs | 2,114 | - | - | - | - |
Other Operating Expenses | 10,649 | 11,981 | 11,667 | 10,922 | 11,100 |
Total Operating Expenses | 71,834 | 65,437 | 64,694 | 65,143 | 60,497 |
Operating Income | 5,250 | 5,545 | 2,207 | 3,621 | 8,191 |
Interest Expense | -1,061 | -1,037 | -1,045 | -938 | -920 |
Currency Exchange Gain (Loss) | - | 5 | 6 | 7 | 10 |
Other Non Operating Income (Expenses) | 508 | 1,109 | 994 | 3,674 | 1,237 |
EBT Excluding Unusual Items | 4,697 | 5,622 | 2,162 | 6,364 | 8,518 |
Gain (Loss) on Sale of Assets | -36 | - | - | - | - |
Pretax Income | 4,661 | 5,622 | 2,162 | 6,364 | 8,518 |
Income Tax Expense | 1,258 | 1,178 | 560 | 1,062 | 1,642 |
Earnings From Continuing Ops. | 3,403 | 4,444 | 1,602 | 5,302 | 6,876 |
Net Income to Company | 3,403 | 4,444 | 1,602 | 5,302 | 6,876 |
Minority Interest in Earnings | -24 | -18 | -24 | -18 | -21 |
Net Income | 3,379 | 4,426 | 1,578 | 5,284 | 6,855 |
Preferred Dividends & Other Adjustments | 206 | 200 | 198 | 185 | 201 |
Net Income to Common | 3,173 | 4,226 | 1,380 | 5,099 | 6,654 |
Net Income Growth | -23.66% | 180.48% | -70.14% | -22.92% | 26.78% |
Shares Outstanding (Basic) | 673 | 706 | 758 | 803 | 863 |
Shares Outstanding (Diluted) | 673 | 711 | 762 | 809 | 869 |
Shares Change (YoY) | -5.32% | -6.72% | -5.76% | -6.96% | -4.80% |
EPS (Basic) | 4.71 | 5.98 | 1.82 | 6.35 | 7.71 |
EPS (Diluted) | 4.71 | 5.94 | 1.81 | 6.30 | 7.65 |
EPS Growth | -20.71% | 228.18% | -71.27% | -17.65% | 34.68% |
Dividend Per Share | 2.248 | 2.155 | 2.060 | 1.980 | 1.900 |
Dividend Growth | 4.29% | 4.61% | 4.04% | 4.21% | 4.40% |
Operating Margin | 6.81% | 7.81% | 3.30% | 5.27% | 11.92% |
Profit Margin | 4.12% | 5.95% | 2.06% | 7.41% | 9.69% |
EBITDA | 5,366 | 6,259 | 2,925 | 4,294 | 8,885 |
EBITDA Margin | 6.96% | 8.82% | 4.37% | 6.25% | 12.93% |
D&A For EBITDA | 116 | 714 | 718 | 673 | 694 |
EBIT | 5,250 | 5,545 | 2,207 | 3,621 | 8,191 |
EBIT Margin | 6.81% | 7.81% | 3.30% | 5.27% | 11.92% |
Effective Tax Rate | 26.99% | 20.95% | 25.90% | 16.69% | 19.28% |
Revenue as Reported | 77,084 | 70,986 | 66,905 | 68,770 | 68,696 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.